Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials


Department of AnesthesiologyJinling Hospital, Nanjing University School of Medicine, Nanjing, China


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT01573741

Organisation Name: Jinling Hospital, China

Overal Status: Unknown status

Start Date: February 2012

Last Update: May 4, 2012

Lead Sponsor: Shi Jinyun

Brief Summary: Primary Outcome Measures:

Evaluate the changes in neuroimaging and biochemistry measures with ketamine treatment.

Secondary Outcome Measures:

Evaluate the effects of ketamine on depression symptoms, manic symptoms, global change in psychiatric symptoms, and suicidal ideation.

Conditions:
  • Major Depressive Disorder


Total execution time in seconds: 0.21559000015259